The Effects of Late Toxicities on Outcomes in Long-Term Survivors of Ex-Vivo CD34+− Selected Allogeneic Hematopoietic Cell Transplantation

The late adverse events in long-term survivors after myeloablative conditioned allogeneic hematopoietic cell transplantation with ex-vivo CD34+ selection are not well characterized. Using the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) version 4.0, we asses...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Biol Blood Marrow Transplant
Autori principali: Scordo, Michael, Shah, Gunjan L., Kosuri, Satyajit, Herrera, Diego Adrianzen, Cho, Christina, Devlin, Sean M., Maloy, Molly A., Nieves, Jimmy, Borrill, Taylor, Avecilla, Scott T., Meagher, Richard C., Carlow, Dean C., O’Reilly, Richard J., Papadopoulos, Esperanza B., Jakubowski, Ann A., Koehne, Guenther, Gyurkocza, Boglarka, Castro-Malaspina, Hugo, Tamari, Roni, Perales, Miguel-Angel, Giralt, Sergio A., Shaffer, Brian C.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2017
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6713288/
https://ncbi.nlm.nih.gov/pubmed/28870777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2017.08.033
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi